We've found 20 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.
CorVel’s first quarter 2025 results give investors plenty to think about. The headline figures, a strong lift in both sales and profits, speak to effective cost management and persistent revenue momentum, keeping the company’s recent streak of progress intact. The active share buyback program may appeal to those focused on shareholder returns and possible EPS support in the near term. These updates could influence short-term market sentiment, but the fundamentals around valuation and industry outlook remain critical. The company still trades at a higher price-to-earnings ratio than the sector, while recent price weakness raises questions about how much of the good news is already priced in. For now, improving profit margins appear to temper some downside risk, but further insider selling or broader healthcare sector shifts could quickly change the narrative.
But keep in mind, significant insider selling is something investors should pay close attention to. CorVel's shares have been on the rise but are still potentially undervalued by 8%. Find out what it's worth.Explore another fair value estimate on CorVel - why the stock might be worth just $95.17!
Disagree with this assessment? Create your own narrative in under 3 minutes - extraordinary investment returns rarely come from following the herd.
Our top stock finds are flying under the radar-for now. Get in early:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com